Beside NT-proBNP, also recipient’s age at transplant > 56.60 years (HR 2.47; p = 0.04), cholesterol above 200 mg/dl (HR 4.03; p < 0.01), coronary artery disease (HR 9.87; p < 0.01) and history of myocardial infarction (HR 2.82; p = 0.04) (Table 2) could be identified as risk factors for MACE. Here, NPPB is linked to coronary artery disorder.